Document
IPR2023-00724, No. 2088 Exhibit - EX2088 American College of Cardiology, Clinical Topics, Diabetes and Cardiometabolic Disease, httpswwwaccorgClinical TopicsDiabetes and Cardiometabol...
Cite Document
IPR2023-00724, No. 2088 Exhibit - EX2088 American College of Cardiology, Clinical Topics, Diabetes and Cardiometabolic Disease, httpswwwaccorgClinical TopicsDiabetes and Cardiometabolic Disease last
+ More Snippets
Document
IPR2023-00724, No. 2068 Exhibit - EX2068 Victoza® Prescribing Information January 2010 (P.T.A.B. Jan. 17, 2024)
Cite Document
IPR2023-00724, No. 2068 Exhibit - EX2068 Victoza® Prescribing Information January 2010 (P.T.A.B. Jan. 17, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2057 Exhibit - EX2057 Declaration of Jenna DiCicco (P.T.A.B. Jan. 17, 2024)
Cite Document
IPR2023-00724, No. 2057 Exhibit - EX2057 Declaration of Jenna DiCicco (P.T.A.B. Jan. 17, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2437 Exhibit - EX2437 US Food Drug Administration, DrugsFDA, Tanzeum® (P.T.A.B. Jan. 17, 2024)
Cite Document
IPR2023-00724, No. 2437 Exhibit - EX2437 US Food Drug Administration, DrugsFDA, Tanzeum® (P.T.A.B. Jan. 17, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2060 Exhibit - EX2060 Rosenstock, J, et al, “The Fate of Taspoglutide, a Weekly GLP 1 Receptor Agonist, Versus Twice Daily Exenatide for Type 2 Diabetes,” Diabetes Care...
Cite Document
IPR2023-00724, No. 2060 Exhibit - EX2060 Rosenstock, J, et al, “The Fate of Taspoglutide, a Weekly GLP 1 Receptor Agonist, Versus Twice Daily Exenatide for Type 2 Diabetes,” Diabetes Care, Vol36, 49
+ More Snippets
Document
IPR2023-00724, No. 2375 Exhibit - EX2375 US Food Drug Administration, Approval Letter for Januvia® Oct 16, 2006 (P.T.A.B. Jan. 17, 2024)
Cite Document
IPR2023-00724, No. 2375 Exhibit - EX2375 US Food Drug Administration, Approval Letter for Januvia® Oct 16, 2006 (P.T.A.B. Jan. 17, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2521 Exhibit - EX2521 Bibeau, WS, et al, Impact of Out of Pocket Pharmacy Costs on Branded Medication Adherence Among Patients with Type 2 Diabetes, J Manag Care ...
Cite Document
IPR2023-00724, No. 2521 Exhibit - EX2521 Bibeau, WS, et al, Impact of Out of Pocket Pharmacy Costs on Branded Medication Adherence Among Patients with Type 2 Diabetes, J Manag Care Spec Pharm, 2016
+ More Snippets
Document
IPR2023-00724, No. 2403 Exhibit - EX2403 Onglyza® Prescribing Information rev Feb 2017 (P.T.A.B. Jan. 17, 2024)
Cite Document
IPR2023-00724, No. 2403 Exhibit - EX2403 Onglyza® Prescribing Information rev Feb 2017 (P.T.A.B. Jan. 17, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2525 Exhibit - EX2525 Eli Lilly Co, 2018 Financial Report (P.T.A.B. Jan. 17, 2024)
Cite Document
IPR2023-00724, No. 2525 Exhibit - EX2525 Eli Lilly Co, 2018 Financial Report (P.T.A.B. Jan. 17, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2378 Exhibit - EX2378 American Diabetes Association, “Life with Diabetes Get the Right Care for You,” httpwwwdiabetesorgliving with diabetestreatment and care (P.T.A.B....
Cite Document
IPR2023-00724, No. 2378 Exhibit - EX2378 American Diabetes Association, “Life with Diabetes Get the Right Care for You,” httpwwwdiabetesorgliving with diabetestreatment and care (P.T.A.B. Jan. 17, 2
+ More Snippets
Document
IPR2023-00724, No. 1033 Exhibit - Knudsen 2010 (P.T.A.B. Mar. 16, 2023)
Cite Document
IPR2023-00724, No. 1033 Exhibit - Knudsen 2010 (P.T.A.B. Mar. 16, 2023)
+ More Snippets
Document
IPR2023-00724, No. 1087 Exhibit - 003 file history excerpt (P.T.A.B. Mar. 16, 2023)
Cite Document
IPR2023-00724, No. 1087 Exhibit - 003 file history excerpt (P.T.A.B. Mar. 16, 2023)
+ More Snippets
Document
IPR2023-00724, No. 1020 Exhibit - Bydureon label 2012 (P.T.A.B. Mar. 16, 2023)
Cite Document
IPR2023-00724, No. 1020 Exhibit - Bydureon label 2012 (P.T.A.B. Mar. 16, 2023)
+ More Snippets
Document
IPR2023-00724, No. 1073 Exhibit - US6458924 (P.T.A.B. Mar. 16, 2023)
Cite Document
IPR2023-00724, No. 1073 Exhibit - US6458924 (P.T.A.B. Mar. 16, 2023)
+ More Snippets
Document
IPR2023-00724, No. 1061 Exhibit - US20110166321 (P.T.A.B. Mar. 16, 2023)
Cite Document
IPR2023-00724, No. 1061 Exhibit - US20110166321 (P.T.A.B. Mar. 16, 2023)
+ More Snippets